Search

everythinglearnresearchcommunity

for

Search:↓

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Finasteride side effects in young men may be linked to specific gene variations.

No clear link between androgen receptor variation and hair loss, but more research needed.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Hair loss gene linked to prostate issues.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Certain gene variations might be linked to severe acne in women but not in men.

No significant link between CAG repeat numbers and female pattern hair loss in Han Chinese population.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

The study created a new method to test drugs that affect hormone processing in skin.

No clear link between specific gene and hair loss in Mexican brothers.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Hsc70 protein may influence hair growth by responding to androgens.

Mice without the vitamin D receptor have bone issues and other health problems, suggesting vitamin D is important for preventing various diseases in humans.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Longer CAG repeats in gene linked to more severe hair loss in females.